Evidence map›Paper›PMID 32145367›Full record

ArticleJournal of clinical epidemiology2020

Future of evidence ecosystem series: 1. Introduction Evidence synthesis ecosystem needs dramatic change.

Isabelle Boutron, Perrine Créquit, Hywel Williams, Joerg Meerpohl, Jonathan C Craig, Philippe Ravaud

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Journal of clinical epidemiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
9.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Article
  3. Implementation of artificial intelligence (AI) in ASD treatment.North American Spine Society journal · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Ethical challenges for Health Technology Assessment (HTA) in the evolving evidence landscape.International journal of technology assessment in health care · 2024
    Review
  8. Article
  9. Making guidelines computable.Clinical and public health guidelines · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Guidance to best tools and practices for systematic reviews1.Journal of pediatric rehabilitation medicine · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 5 countries.

Isabelle BoutronINSERM, UMR1153, Epidemiology and Biostatistics Sorbonne Paris Cité Center (CRESS), METHODS Team, Paris, France; Centre d'Epidémiologie Clinique, AP-HP (Assistance Publique des Hôpitaux de Paris), Hôpital Hôtel Dieu, Paris, France; French Cochrane Center, Paris, France; Paris Descartes University, Sorbonne Paris Cité, Faculté de Médecine, Paris, France. Electronic address: isabelle.boutron@aphp.fr.
Perrine CréquitINSERM, UMR1153, Epidemiology and Biostatistics Sorbonne Paris Cité Center (CRESS), METHODS Team, Paris, France; French Cochrane Center, Paris, France; Direction de la recherche Clinique, Hôpital Foch, Suresnes, France.
Hywel WilliamsCentre of Evidence Based Dermatology, University of Nottingham, Nottingham, United Kingdom.
Joerg MeerpohlInstitute for Evidence in Medicine (For Cochrane Germany Foundation), Medical Centre of the University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Jonathan C CraigCollege of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia.
Philippe RavaudINSERM, UMR1153, Epidemiology and Biostatistics Sorbonne Paris Cité Center (CRESS), METHODS Team, Paris, France; Centre d'Epidémiologie Clinique, AP-HP (Assistance Publique des Hôpitaux de Paris), Hôpital Hôtel Dieu, Paris, France; French Cochrane Center, Paris, France; Paris Descartes University, Sorbonne Paris Cité, Faculté de Médecine, Paris, France; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.
Centre de Recherche Épidémiologie et StatistiqueDélégation Paris 5 · FRFlinders University · AUUniversité Paris Cité · FRUniversity of Freiburg · DEUniversity of Nottingham · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis article presents why the planning, conduct, and reporting of systematic reviews and meta-analyses of therapeutic interventions are suboptimal. STUDY DESIGN AND

settingWe present an overview of the limitations of the current system of evidence synthesis for therapeutic interventions.

resultsSystematic reviews and meta-analyses are a cornerstone of health care decisions. However, despite the increasing a number of published systematic reviews of therapeutic interventions, the current evidence synthesis ecosystem is not properly addressing stakeholders' needs. The current production process leads to a series of disparate systematic reviews because of erratic and inefficient planning with a process that is not always comprehensive and is prone to bias. Evidence synthesis depends on the quality of primary research, so primary research that is not available is biased or selectively reported raises important concerns. Moreover, the lack of interactions between the community of primary research producers and systematic reviewers impedes the optimal use of data. The context has considerably evolved, with ongoing research innovations, a new medical approach with the end of the one-size-fits-all approach, more available data, and new patient expectations. All these changes must be introduced into the future evidence ecosystem.

conclusionDramatic changes are needed to enable this future ecosystem to become user driven and user oriented and more useful for decision-making.

Indexed as

Meta-Analysis as TopicBiasData ManagementHumansResearch DesignSystematic Reviews as TopicDecision-makingEvidence synthesis ecosystemMeta-analysisMethodsSystematic reviewWaste in research

Identifiers

PMID32145367
OpenAlexW3009200616

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.